Clinical trial
Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic…
NCT00229437 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00229437 |
|---|---|
| Title | Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy |
| Official title | A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Three Doses of TAK-128 in Subjects With Mild to Moderate Diabetic Peripheral Neuropathy |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Neuropathies |
| Intervention type | Drug |
| Interventions | TAK-128, Placebo |
| Enrollment | 343 |
| Start date | Mar 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Sep 29, 2005 |
| Last update posted | Feb 28, 2012 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: